BR112018076573A2 - método para a produção de uma forma de dosagem - Google Patents
método para a produção de uma forma de dosagemInfo
- Publication number
- BR112018076573A2 BR112018076573A2 BR112018076573-2A BR112018076573A BR112018076573A2 BR 112018076573 A2 BR112018076573 A2 BR 112018076573A2 BR 112018076573 A BR112018076573 A BR 112018076573A BR 112018076573 A2 BR112018076573 A2 BR 112018076573A2
- Authority
- BR
- Brazil
- Prior art keywords
- dosage form
- granules
- producing
- tablets
- nutraceutical
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1682—Processes
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L27/00—Spices; Flavouring agents or condiments; Artificial sweetening agents; Table salts; Dietetic salt substitutes; Preparation or treatment thereof
- A23L27/70—Fixation, conservation, or encapsulation of flavouring agents
- A23L27/77—Use of inorganic solid carriers, e.g. silica
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L29/00—Foods or foodstuffs containing additives; Preparation or treatment thereof
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L29/00—Foods or foodstuffs containing additives; Preparation or treatment thereof
- A23L29/015—Inorganic compounds
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23P—SHAPING OR WORKING OF FOODSTUFFS, NOT FULLY COVERED BY A SINGLE OTHER SUBCLASS
- A23P10/00—Shaping or working of foodstuffs characterised by the products
- A23P10/20—Agglomerating; Granulating; Tabletting
- A23P10/25—Agglomeration or granulation by extrusion or by pressing, e.g. through small holes, through sieves or between surfaces
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/075—Ethers or acetals
- A61K31/085—Ethers or acetals having an ether linkage to aromatic ring nuclear carbon
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/192—Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
- A61K8/0216—Solid or semisolid forms
- A61K8/022—Powders; Compacted Powders
- A61K8/0225—Granulated powders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/19—Cosmetics or similar toiletry preparations characterised by the composition containing inorganic ingredients
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1611—Inorganic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2009—Inorganic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
- A61K9/2077—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4841—Filling excipients; Inactive ingredients
- A61K9/485—Inorganic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/10—General cosmetic use
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
- A61K2800/41—Particular ingredients further characterized by their size
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
- A61K2800/41—Particular ingredients further characterized by their size
- A61K2800/412—Microsized, i.e. having sizes between 0.1 and 100 microns
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/80—Process related aspects concerning the preparation of the cosmetic composition or the storage or application thereof
- A61K2800/805—Corresponding aspects not provided for by any of codes A61K2800/81 - A61K2800/95
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q11/00—Preparations for care of the teeth, of the oral cavity or of dentures; Dentifrices, e.g. toothpastes; Mouth rinses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q15/00—Anti-perspirants or body deodorants
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Inorganic Chemistry (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- Birds (AREA)
- Nutrition Science (AREA)
- Dermatology (AREA)
- Mycology (AREA)
- Medicinal Preparation (AREA)
- Cosmetics (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
Abstract
Applications Claiming Priority (5)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP16175590.5A EP3260114A1 (en) | 2016-06-21 | 2016-06-21 | Method for the production of a dosage form |
EP16175590.5 | 2016-06-21 | ||
US201662355394P | 2016-06-28 | 2016-06-28 | |
US62/355,394 | 2016-06-28 | ||
PCT/EP2017/064950 WO2017220498A1 (en) | 2016-06-21 | 2017-06-19 | Method for the production of a dosage form |
Publications (1)
Publication Number | Publication Date |
---|---|
BR112018076573A2 true BR112018076573A2 (pt) | 2019-04-16 |
Family
ID=56194339
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BR112018076573-2A BR112018076573A2 (pt) | 2016-06-21 | 2017-06-19 | método para a produção de uma forma de dosagem |
Country Status (10)
Country | Link |
---|---|
US (1) | US11400050B2 (pt) |
EP (2) | EP3260114A1 (pt) |
JP (1) | JP7014787B2 (pt) |
KR (1) | KR20190020055A (pt) |
CN (1) | CN109310636A (pt) |
BR (1) | BR112018076573A2 (pt) |
CA (1) | CA3028247A1 (pt) |
RU (1) | RU2019101040A (pt) |
TW (1) | TW201803554A (pt) |
WO (1) | WO2017220498A1 (pt) |
Families Citing this family (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP3400810A1 (en) * | 2017-05-11 | 2018-11-14 | Omya International AG | Surface-reacted calcium carbonate in food |
CN111419815B (zh) * | 2020-04-23 | 2022-03-11 | 永信药品工业(昆山)股份有限公司 | 依托考昔片及其优化方法 |
TW202200206A (zh) * | 2020-04-28 | 2022-01-01 | 瑞士商歐米亞國際公司 | 包含表面反應碳酸鈣作為賦形劑之顆粒 |
AU2021263871A1 (en) * | 2020-04-28 | 2022-09-29 | Omya International Ag | Method for the production of free-flowing granules |
WO2021259560A1 (en) | 2020-06-25 | 2021-12-30 | Omya International Ag | Co-ground active(s) comprising product comprising surface-reacted calcium carbonate |
FR3133841A1 (fr) * | 2022-03-24 | 2023-09-29 | Laboratoires Paris Dome | Dispositif et procédé de compactage d’une poudre |
EP4311543A1 (en) * | 2022-07-27 | 2024-01-31 | Galvita AG | Methods for loading template inverted carriers |
Family Cites Families (28)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4985459A (en) | 1984-02-08 | 1991-01-15 | Richardson-Vicks, Inc. | Analgesic and anti-inflammatory compositions comprising diphenhydramine and methods of using same |
EP0872544A1 (en) | 1997-04-14 | 1998-10-21 | The Procter & Gamble Company | Dry effervescent granules and granular compositions comprising the same |
US5939091A (en) * | 1997-05-20 | 1999-08-17 | Warner Lambert Company | Method for making fast-melt tablets |
FR2787802B1 (fr) | 1998-12-24 | 2001-02-02 | Pluss Stauffer Ag | Nouvelle charge ou pigment ou mineral traite pour papier, notamment pigment contenant du caco3 naturel, son procede de fabrication, compositions les contenant, et leurs applications |
US6582738B2 (en) | 1999-09-13 | 2003-06-24 | Deseret Laboratories, Inc. | Process for preparing chewing gum containing a nutritional supplement |
US20030157213A1 (en) | 2002-02-19 | 2003-08-21 | Jeffrey Jenkins | Nutrient chewing gum |
FR2852600B1 (fr) | 2003-03-18 | 2005-06-10 | Nouveau pigment mineral contenant du carbonate de calcium, suspension aqueuse le contenant et ses usages | |
ES2523148T3 (es) | 2004-05-24 | 2014-11-21 | Takeda Nycomed As | Material en forma de partículas que comprende un compuesto que contiene calcio y un alcohol de azúcar |
MY139913A (en) | 2004-06-01 | 2009-11-30 | Nycomed Pharma As | Chewable, suckable and swallowable tablet containing a calcium-containing compound as an active substance |
FR2871474B1 (fr) | 2004-06-11 | 2006-09-15 | Omya Development Ag | Nouveau pigment mineral sec contenant du carbonate de calcium, suspension aqueuse le contenant et ses usages |
AU2005256321B2 (en) | 2004-06-29 | 2008-11-20 | Takeda Pharma A/S | Manufacturing of quick release pharmaceutical compositions of water insoluble drugs and pharmaceutical compositions obtained by the process of the invention |
KR20060058415A (ko) * | 2004-11-25 | 2006-05-30 | 지엘팜텍 주식회사 | 아목시실린 및 클라불란산 또는 그의 염의 혼합물 함유조성물 및 그의 제조방법 |
CA2631821C (en) | 2005-12-07 | 2014-03-11 | Nycomed Pharma As | Pre-compacted calcium-containing compositions |
ATE480597T1 (de) | 2007-12-12 | 2010-09-15 | Omya Development Ag | Verfahren zur herstellung von oberflächenreaktives fällungskalziumkarbonat |
PE20100252A1 (es) * | 2008-06-06 | 2010-04-12 | Boehringer Ingelheim Int | Nuevas formulaciones farmaceuticas solidas que comprenden dimaleato de 4-[(3-cloro-4-fluorofenil) amino]-6-{[4-(n,n-dimetilamino)-1-oxo-2-buten-1-il] amino}-7-((s)-tetrahidrofuran-3-iloxi)-quinazolina |
EP2168572A1 (en) | 2008-09-30 | 2010-03-31 | Omya Development Ag | New controlled release active agent carrier |
WO2010054845A1 (en) | 2008-11-17 | 2010-05-20 | Nycomed Pharma As | Improved dissolution stability of calcium carbonate tablets |
ATE542862T1 (de) | 2009-06-15 | 2012-02-15 | Omya Development Ag | Verfahren zur herstellung von oberflächenreaktivem kalziumkarbonat und verwendung |
ATE545682T1 (de) | 2009-06-15 | 2012-03-15 | Omya Development Ag | Verfahren zur herstellung eines an der oberfläche reagierten calciumcarbonats, das eine schwache säure anwendet |
WO2013100112A1 (ja) | 2011-12-28 | 2013-07-04 | ニプロ株式会社 | アンギオテンシンii拮抗作用を有する化合物を含有する固形医薬組成物 |
EP2719376B1 (en) | 2012-10-12 | 2015-03-04 | Omya International AG | Gastroretentive drug formulation and delivery systems and their method of preparation using functionalized calcium carbonate |
ES2628371T3 (es) * | 2012-10-12 | 2017-08-02 | Omya International Ag | Formulación de forma farmacéutica sólida de disgregación rápida que comprende carbonato de calcio funcionalizado y método para su fabricación |
EP2957603A1 (en) * | 2014-06-20 | 2015-12-23 | Omya International AG | Method for the production of granules comprising surface-reacted calcium carbonate |
ES2667337T3 (es) | 2014-09-22 | 2018-05-10 | Omya International Ag | Carbonato de calcio tratado mediante reacción superficial para su uso como agente antiapelmazante |
EP3034070A1 (en) | 2014-12-18 | 2016-06-22 | Omya International AG | Method for the production of a pharmaceutical delivery system |
EP3069713A1 (en) * | 2015-03-20 | 2016-09-21 | Omya International AG | Dispersible dosage form |
EP3176222A1 (en) | 2015-12-01 | 2017-06-07 | Omya International AG | Method for the production of granules comprising surface-reacted calcium carbonate |
EP3260115A1 (en) * | 2016-06-21 | 2017-12-27 | Omya International AG | Method for the production of a dosage form |
-
2016
- 2016-06-21 EP EP16175590.5A patent/EP3260114A1/en not_active Withdrawn
-
2017
- 2017-06-19 KR KR1020197001508A patent/KR20190020055A/ko not_active Application Discontinuation
- 2017-06-19 WO PCT/EP2017/064950 patent/WO2017220498A1/en unknown
- 2017-06-19 JP JP2019520474A patent/JP7014787B2/ja active Active
- 2017-06-19 EP EP17733402.6A patent/EP3471707B1/en active Active
- 2017-06-19 RU RU2019101040A patent/RU2019101040A/ru unknown
- 2017-06-19 CA CA3028247A patent/CA3028247A1/en not_active Abandoned
- 2017-06-19 BR BR112018076573-2A patent/BR112018076573A2/pt not_active IP Right Cessation
- 2017-06-19 CN CN201780037769.2A patent/CN109310636A/zh active Pending
- 2017-06-19 TW TW106120363A patent/TW201803554A/zh unknown
- 2017-06-19 US US16/309,148 patent/US11400050B2/en active Active
Also Published As
Publication number | Publication date |
---|---|
EP3260114A1 (en) | 2017-12-27 |
JP2019520428A (ja) | 2019-07-18 |
JP7014787B2 (ja) | 2022-02-01 |
EP3471707B1 (en) | 2022-09-14 |
CA3028247A1 (en) | 2017-12-28 |
RU2019101040A3 (pt) | 2020-10-02 |
US11400050B2 (en) | 2022-08-02 |
RU2019101040A (ru) | 2020-07-21 |
US20190328668A1 (en) | 2019-10-31 |
TW201803554A (zh) | 2018-02-01 |
CN109310636A (zh) | 2019-02-05 |
EP3471707A1 (en) | 2019-04-24 |
WO2017220498A1 (en) | 2017-12-28 |
KR20190020055A (ko) | 2019-02-27 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
BR112018076570A2 (pt) | método para a produção de uma forma de dosagem | |
BR112018076573A2 (pt) | método para a produção de uma forma de dosagem | |
BR112015025545A2 (pt) | cápsula de dose individual com um distribuidor de líquido | |
BR112014023234A2 (pt) | composição de estabilização seca para um material bioativo, tablete, pílula ou pelota, métodos de produção dos mesmos e produtos que os compreendem | |
DOP2017000105A (es) | Métodos y productos de fármaco para tratar enfermedad de alzheimer | |
BR112014024903A2 (pt) | anticorpos biespecíficos contra tweak humanao e il17 humana e seus usos | |
GT201600142A (es) | Composiciones farmacéuticas que comprenden azd9291 | |
BR112015014372A2 (pt) | inibidores de autotaxina | |
BR112017001192A2 (pt) | composições de açúcar para preparação de tabletes por meio de compressão direta | |
BR112012027217A2 (pt) | aparelho de formação de produto alimentício. | |
BR112017000453A2 (pt) | processos para fabricar um material contendo carbonato de cálcio e para produzir um produto polimérico, material contendo carbonato de cálcio, material particulado, e, usos do processo e de um material particulado. | |
UY36444A (es) | Método para producir sistema de administración farmacéutica, uso de carbonato de calcio y sistema de administración farmacéutica obtenido por método | |
BR112016006623A2 (pt) | biscoito para o café da manhã com glicose de liberação lenta | |
BR112016025876A8 (pt) | composição, processos para preparar uma microcápsula e uma forma de dosagem unitária, forma de dosagem unitária, microcápsula, produto, uso de uma composição, e, método para tratar uma condição associada à vitamina k1 ou k2 | |
BR112017019927A2 (pt) | método para produzir uma forma de dosagem dispersível, grânulos, comprimidos, formas de dosagem, e, uso dos grânulos, de comprimidos, e de material, produtos farmacêuticos, nutracêuticos, cosméticos, de cuidado doméstico e pessoal | |
BR112015031417A8 (pt) | forma de dosagem farmacêutica, composição farmacêutica, métodos para tratamento de um paciente com necessidade de cisteamina e para preparo de uma forma de dosagem | |
BR112018002036A2 (pt) | método para o controle das pragas de um vegetal de algodão e utilização de um ou mais componentes da árvore de ginkgo | |
BR112017000898A2 (pt) | oritavancina de alta pureza e método de produção da mesma | |
EA201691860A1 (ru) | Пептидный медикамент в виде сухого порошка | |
AR108935A1 (es) | Extracto de aquenio de silybum marianum y sus usos en dermatología y dermocosmética | |
BR112017006779A2 (pt) | composição farmacêutica oral de baixa dose seu processo de preparação e método de tratamento | |
BR112016027383A8 (pt) | derivados de naftiridinadiona, seus usos, composição farmacêutica e combinação | |
CO2019002361A2 (es) | 1–arilnaftiridin–3–carboxamidas 7–sustituidas y su uso | |
EA201690936A1 (ru) | Применение цистеамина и его производных для лечения митохондриальных заболеваний | |
BR112016000210A2 (pt) | Vacinas sintéticas contra streptococcus pneumoniae tipo 1 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
B07D | Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette] |
Free format text: DE ACORDO COM O ARTIGO 229-C DA LEI NO 10196/2001, QUE MODIFICOU A LEI NO 9279/96, A CONCESSAO DA PATENTE ESTA CONDICIONADA A ANUENCIA PREVIA DA ANVISA. CONSIDERANDO A APROVACAO DOS TERMOS DO PARECER NO 337/PGF/EA/2010, BEM COMO A PORTARIA INTERMINISTERIAL NO 1065 DE 24/05/2012, ENCAMINHA-SE O PRESENTE PEDIDO PARA AS PROVIDENCIAS CABIVEIS. |
|
B07E | Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette] | ||
B06W | Patent application suspended after preliminary examination (for patents with searches from other patent authorities) chapter 6.23 patent gazette] | ||
B350 | Update of information on the portal [chapter 15.35 patent gazette] | ||
B08F | Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette] |
Free format text: REFERENTE A 6A ANUIDADE. |
|
B08K | Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette] |
Free format text: EM VIRTUDE DO ARQUIVAMENTO PUBLICADO NA RPI 2727 DE 11-04-2023 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDO O ARQUIVAMENTO DO PEDIDO DE PATENTE, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013. |